State Street Portfolio holdings
State Street Corporation, established in 1792 and headquartered in Boston, Massachusetts, is one of the oldest financial institutions in the United States and a major player in the global asset management and custody banking sectors. Primarily known for its custodial services, it safeguards assets for institutional investors, managing trillions of dollars through its State Street Global Advisors (SSGA) division, which is renowned for launching the first U.S. exchange-traded fund (ETF), the SPDR S&P 500 ETF (SPY), in 1993. The company provides a range of services including investment management, research, trading, and data analytics, catering mostly to institutional clients like pension funds, endowments, and mutual funds. With a focus on financial infrastructure and innovation, State Street has positioned itself as a key backbone in the global investment ecosystem.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$3.42B |
| 2 |
Cigna
CI
|
+$1.25B |
| 3 |
CVS Health
CVS
|
+$1.25B |
| 4 |
Marathon Petroleum
MPC
|
+$805M |
| 5 |
Diamondback Energy
FANG
|
+$589M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$3.86B |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$2.31B |
| 3 |
PX
Praxair Inc
PX
|
+$2.1B |
| 4 |
Apple
AAPL
|
+$1.38B |
| 5 |
ANDV
Andeavor
ANDV
|
+$1.1B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.79% |
| 2 | Technology | 15.42% |
| 3 | Healthcare | 14.78% |
| 4 | Industrials | 11.06% |
| 5 | Consumer Discretionary | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
Harmony Gold Mining
HMY
$10.5B
| $156K | ﹤0.01% |
87,300
+40,300
| +86% | +$70.7K |
|
|
LFT
3502
Lument Finance Trust
LFT
$35.4M
| $155K | ﹤0.01% |
53,229
+31,236
| +142% | +$106K |
|
3503
American Realty Investors
ARL
$251M
| $154K | ﹤0.01% |
12,726
+2,492
| +24% | +$38.4K |
|
3504
ING
ING
$101B
| $154K | ﹤0.01% |
14,463
+191
| +1% | +$2.29K |
|
|
RVLP
3505
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $152K | ﹤0.01% |
+19,600
| New | +$157K |
|
|
HTGM
3506
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
| $151K | ﹤0.01% |
330
+204
| +162% | +$126K |
|
|
STKL
3507
DELISTED
SunOpta
STKL
| $148K | ﹤0.01% |
38,343
+2,942
| +8% | +$16.8K |
|
|
FINV
3508
FinVolution Group
FINV
$1.16B
| $145K | ﹤0.01% |
40,235
+2,335
| +6% | +$12.5K |
|
|
EMKR
3509
DELISTED
Emcore Corp
EMKR
| $143K | ﹤0.01% |
3,394
-11
| -0.3% | -$516 |
|
|
IDEX
3510
DELISTED
Ideanomics, Inc. Common Stock
IDEX
| $140K | ﹤0.01% |
931
+136
| +17% | +$41.9K |
|
3511
Lee Enterprises
LEE
$181M
| $139K | ﹤0.01% |
6,608
-124
| -2% | -$3.07K |
|
3512
LSI Industries
LYTS
$908M
| $138K | ﹤0.01% |
43,578
-679
| -2% | -$2.83K |
|
3513
Mizuho Financial
MFG
$126B
| $134K | ﹤0.01% |
44,519
| – | – |
|
3514
Xenon Pharmaceuticals
XENE
$6.19B
| $134K | ﹤0.01% |
21,288
+1,788
| +9% | +$15.9K |
|
3515
Nomura Holdings
NMR
$28.5B
| $133K | ﹤0.01% |
35,760
| – | – |
|
|
DMK
3516
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
| $131K | ﹤0.01% |
831
-8
| -1% | -$1.53K |
|
3517
Dianthus Therapeutics
DNTH
$6.04B
| $128K | ﹤0.01% |
+1,406
| New | +$192K |
|
3518
IDT Corp
IDT
$1.67B
| $127K | ﹤0.01% |
20,437
+222
| +1% | +$1.58K |
|
3519
Mitsubishi UFJ Financial
MUFG
$246B
| $124K | ﹤0.01% |
25,536
| – | – |
|
3520
Talphera
TLPH
$70.6M
| $122K | ﹤0.01% |
2,630
-28
| -1% | -$1.88K |
|
|
CVRS
3521
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
| $121K | ﹤0.01% |
143,572
-3,505
| -2% | -$4.18K |
|
|
FENG
3522
Phoenix New Media
FENG
$18.3M
| $119K | ﹤0.01% |
6,173
-13,636
| -69% | -$279K |
|
3523
Marker Therapeutics
MRKR
$20.5M
| $118K | ﹤0.01% |
+2,120
| New | +$155K |
|
3524
XBiotech
XBIT
$68.3M
| $118K | ﹤0.01% |
23,159
-398
| -2% | -$1.63K |
|
|
TUES
3525
DELISTED
Tuesday Morning Corp
TUES
| $115K | ﹤0.01% |
67,818
-1,020
| -1% | -$2.75K |
|
Similar funds
State Street's Q4 2018 Portfolio in Review
As of Q4 2018, State Street held 3,872 positions worth $1.1T, down 16% from $1.3T the previous quarter. Its ten largest holdings account for 17% of the portfolio.
State Street's Q4 2018 filing shows 102 new, 1,442 increased, 2,108 reduced and 110 closed positions. Its largest new stake was Linde: 21,625,224 shares worth $3.37B. The largest sale was Aetna Inc, an estimated $3.86B.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 16% a quarter earlier, followed by Technology and Healthcare.
- State Street's largest Q4 2018 buy was Linde: 21,625,224 shares worth $3.37B.
- State Street added most to Cigna in Q4 2018, an estimated $1.25B increase.
- State Street's biggest Q4 2018 reduction was Apple, cutting an estimated $1.38B.
- State Street fully exited Aetna Inc in Q4 2018, selling an estimated $3.86B.
- State Street's ten largest holdings make up 17% of its $1.1T portfolio in Q4 2018.
- State Street opened 102 new positions and closed 110 in Q4 2018.
- State Street's portfolio value fell 16% quarter-over-quarter to $1.1T.
Based on State Street's 13F filing for Q4 2018, filed 12 Feb 2019.